Jane Street Group, LLC Albireo Pharma, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$16.32 - $26.37 $1.01 Million - $1.63 Million
61,652 New
61,652 $1.19 Million
Q3 2022

Nov 14, 2022
BUY
$16.32 - $26.37 $1.01 Million - $1.63 Million
61,652 New
61,652 $1.19 Million
Q4 2021

Feb 15, 2022
SELL
$21.19 - $31.29 $320,731 - $473,605
-15,136 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$27.36 - $35.98 $414,120 - $544,593
15,136 New
15,136 $472,000

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email